FDA approval for Lilly’s Bydureon delayed until Jan 28
Subsequent to a delay of one year for the approval of once-per-week diabetes drug Bydureon, the United States Food and
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine